Triple receptor agonist under active multi-receptor research investigation.
Retatrutide is an investigational 36-amino acid acylated peptide functioning as a simultaneous agonist at GLP-1, GIP, and glucagon receptors — the first triple hormone receptor agonist studied in metabolic research. Its triagonist mechanism engages GLP-1R for insulin secretion and appetite regulation, GIPR for incretin amplification and lipid metabolism, and GCGR for hepatic glucose production and thermogenesis. This multi-receptor engagement produces distinct downstream signaling compared to mono- or dual-agonist compounds. Supplied as lyophilized powder, ≥99% HPLC purity, LC-MS identity confirmed, endotoxin screened.
Lone Star Peptide ships same-day to research institutions across Texas — Houston, Dallas, Austin, San Antonio and beyond. Same-state logistics, faster delivery, and a supplier who understands the Texas research landscape.
Texas Availability
Lone Star Peptide Co. ships Retatrutide to all Texas addresses for triple GLP-1/GIP/glucagon receptor and obesity research. Same-day dispatch on orders placed before 3 PM CST from our Houston base — Houston, Dallas, Austin, San Antonio, Fort Worth, and every Texas research institution. All batches ship with Freedom Diagnostics COA, HPLC chromatogram, LC-MS identity confirmation, and endotoxin results.
⚠ FOR RESEARCH USE ONLY, Retatrutide is supplied exclusively for in vitro and laboratory research applications. Not approved by the FDA for human consumption or therapeutic use. Not a drug, supplement, or medical treatment. Purchasers are responsible for compliance with all applicable regulations.
Research FAQ